| Landscape of somatic mutations in 560 breast cancer whole-genome sequences S Nik-Zainal, H Davies, J Staaf, M Ramakrishna, D Glodzik, X Zou, ... Nature 534 (7605), 47-54, 2016 | 1203 | 2016 |
| Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer J Jonkers, R Meuwissen, H van der Gulden, H Peterse, M van der Valk, ... Nature genetics 29 (4), 418-425, 2001 | 972 | 2001 |
| Patient-derived xenograft models: an emerging platform for translational cancer research M Hidalgo, F Amant, AV Biankin, E Budinská, AT Byrne, C Caldas, ... Cancer discovery 4 (9), 998-1013, 2014 | 966 | 2014 |
| IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis SB Coffelt, K Kersten, CW Doornebal, J Weiden, K Vrijland, CS Hau, ... Nature 522 (7556), 345-348, 2015 | 849 | 2015 |
| High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs S Rottenberg, JE Jaspers, A Kersbergen, E van der Burg, AOH Nygren, ... Proceedings of the National Academy of Sciences 105 (44), 17079-17084, 2008 | 828 | 2008 |
| 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers P Bouwman, A Aly, JM Escandell, M Pieterse, J Bartkova, ... Nature structural & molecular biology 17 (6), 688, 2010 | 804 | 2010 |
| Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum S Marino, M Vooijs, H van der Gulden, J Jonkers, A Berns Genes & development 14 (8), 994-1004, 2000 | 737 | 2000 |
| The ins and outs of lysophosphatidic acid signaling WH Moolenaar, LA van Meeteren, BNG Giepmans Bioessays 26 (8), 870-881, 2004 | 617 | 2004 |
| Growth inhibition and DNA damage induced by Cre recombinase in mammalian cells A Loonstra, M Vooijs, HB Beverloo, B Al Allak, E van Drunen, R Kanaar, ... Proceedings of the National Academy of Sciences 98 (16), 9209-9214, 2001 | 608 | 2001 |
| Somatic inactivation of E-cadherin and p53 in mice leads to metastatic lobular mammary carcinoma through induction of anoikis resistance and angiogenesis PWB Derksen, X Liu, F Saridin, H van der Gulden, J Zevenhoven, B Evers, ... Cancer cell 10 (5), 437-449, 2006 | 594 | 2006 |
| Exosome transfer from stromal to breast cancer cells regulates therapy resistance pathways MC Boelens, TJ Wu, BY Nabet, B Xu, Y Qiu, T Yoon, DJ Azzam, ... Cell 159 (3), 499-513, 2014 | 538 | 2014 |
| Autotaxin, a secreted lysophospholipase D, is essential for blood vessel formation during development LA Van Meeteren, P Ruurs, C Stortelers, P Bouwman, MA van Rooijen, ... Molecular and cellular biology 26 (13), 5015-5022, 2006 | 536 | 2006 |
| Axin and Frat1 interact with Dvl and GSK, bridging Dvl to GSK in Wnt‐mediated regulation of LEF‐1 L Li, H Yuan, CD Weaver, J Mao, GH Farr, DJ Sussman, J Jonkers, ... The EMBO journal 18 (15), 4233-4240, 1999 | 477 | 1999 |
| The effects of deregulated DNA damage signalling on cancer chemotherapy response and resistance P Bouwman, J Jonkers Nature Reviews Cancer 12 (9), 587-598, 2012 | 464 | 2012 |
| Replication fork stability confers chemoresistance in BRCA-deficient cells AR Chaudhuri, E Callen, X Ding, E Gogola, AA Duarte, JE Lee, N Wong, ... Nature 535 (7612), 382-387, 2016 | 425 | 2016 |
| Somatic loss of BRCA1 and p53 in mice induces mammary tumors with features of human BRCA1-mutated basal-like breast cancer X Liu, H Holstege, H van der Gulden, M Treur-Mulder, J Zevenhoven, ... Proceedings of the National Academy of Sciences 104 (29), 12111-12116, 2007 | 389 | 2007 |
| REV7 counteracts DNA double-strand break resection and affects PARP inhibition G Xu, JR Chapman, I Brandsma, J Yuan, M Mistrik, P Bouwman, ... Nature 521 (7553), 541-544, 2015 | 364 | 2015 |
| A highly efficient ligand‐regulated Cre recombinase mouse line shows that LoxP recombination is position dependent M Vooijs, J Jonkers, A Berns EMBO reports 2 (4), 292-297, 2001 | 363 | 2001 |
| Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors JE Jaspers, A Kersbergen, U Boon, W Sol, L Van Deemter, SA Zander, ... Cancer discovery 3 (1), 68-81, 2013 | 361 | 2013 |
| Interrogating open issues in cancer precision medicine with patient-derived xenografts AT Byrne, DG Alférez, F Amant, D Annibali, J Arribas, AV Biankin, A Bruna, ... Nature Reviews Cancer 17 (4), 254, 2017 | 350 | 2017 |
